Dyslipidemia in Shanghai, China (Q39949079)

15 September 2017

Dyslipidemia in Shanghai, China (English)

1 reference

15 September 2017

1 reference

Jia-Yu Wu

1

1 reference

15 September 2017

Xiao-Yan Duan

2

1 reference

15 September 2017

Lui Li

3

1 reference

15 September 2017

Fei Dai

4

1 reference

15 September 2017

Yan-Yun Li

5

1 reference

15 September 2017

Xing-Jian Li

6

1 reference

15 September 2017

Jian-Gao Fan

7

1 reference

15 September 2017

language of work or name

English

0 references

publication date

15 September 2010

1 reference

15 September 2017

1 reference

15 September 2017

51

1 reference

15 September 2017

5

1 reference

15 September 2017

412-415

1 reference

The new BMI criteria for asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997): the Minnesota Heart Survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Lipids, risk factors and ischaemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Alcohol consumption and metabolic syndrome among Shanghai adults: a randomized multistage stratified cluster sampling investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

The lipid triad, or how to reduce residual cardiovascular risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Are children the future of type 2 diabetes prevention?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Lipids in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan 1980-1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Cardiovascular risk factor changes in Finland, 1972-1997

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

The relationship between dietary factors and serum lipids in Chinese urban and rural populations of Beijing and Guangzhou. PRC-USA Cardiovascular and Cardiopulmonary Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YPMED.2010.08.013

10.1016/J.YPMED.2010.08.013

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference